Bank First (NASDAQ:BFC) reported quarterly earnings of $1.43 per share which missed the analyst consensus estimate of $1.67 by 14.37 percent. This is a 2.05 percent decrease over earnings of $1.46 per share from the same period last year.
Replimune And Incyte Enter Into Clinical Trial Collaboration And Supply Agreement To Evaluate RP1 And INCB99280 In Patients With Cutaneous Squamous Cell Carcinoma
Initial study in the neoadjuvant setting designed to assess RP1 in combination with the small molecule, oral PD-L1 inhibitor, INCB99280
Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company
